Lexicon Pharma (LXRX) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.23 --0%
EPS Growth %: -50.0%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -50.0%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.37 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group
- United Community Banks (UCB) PT Raised to at Piper Sandler Amid 'Several Key Strategic Initiatives'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
